Facial nerve outcome score: a new score to predict long-term facial nerve function after vestibular schwannoma surgery.

facial nerve facial nerve function intraoperative neuromonitoring outcome score restrosigmoid approach vestibular schwannoma

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2023
Historique:
received: 29 01 2023
accepted: 19 05 2023
medline: 28 6 2023
pubmed: 28 6 2023
entrez: 28 6 2023
Statut: epublish

Résumé

Patients' quality of life (QoL), facial nerve (FN), and cochlear nerve (CN) (if conserved) functions should be pursued as final outcomes of vestibular schwannoma (VS) surgery. In regard to FN function, different morphologic and neurophysiological factors have been related to postoperative outcomes. The aim of the current retrospective study was to investigate the impact of these factors on the short- and long-term FN function after VS resection. The combination of preoperative and intraoperative factors resulted in designing and validating a multiparametric score to predict short- and long-term FN function. A single-center retrospective analysis was performed for patients harboring non-syndromic VS who underwent surgical resection in the period 2015-2020. A minimum follow-up period of 12 months was considered among the inclusion criteria. Morphological tumor characteristics, intraoperative neurophysiological parameters, and postoperative clinical factors, namely, House-Brackmann (HB) scale, were retrieved in the study. A statistical analysis was conducted to investigate any relationships with FN outcome and to assess the reliability of the score. Seventy-two patients with solitary primary VS were treated in the period of the study. A total of 59.8% of patients showed an HB value < 3 in the immediate postoperative period (T1), reaching to 76.4% at the last follow-up evaluation. A multiparametric score, Facial Nerve Outcome Score (FNOS), was built. The totality of patients with FNOS grade A showed an HB value < 3 at 12 months, decreasing to 70% for those with FNOS grade B, whereas 100% of patients with FNOS grade C showed an HB value ≥ 3. The ordinal logistic regression showed three times increasing probability to see an HB value ≥ 3 at 3-month follow-up for each worsening point in FNOS score [Exp(B), 2,999; p < 0.001] that was even more probable [Exp(B), 5.486; p < 0.001] at 12 months. The FNOS score resulted to be a reliable score, showing high associations with FN function both at short- and long-term follow-up. Although multicenter studies would be able to increase its reproducibility, it could be used to predict the FN damage after surgery and the potential of restoring its function on the long-term period.

Identifiants

pubmed: 37377918
doi: 10.3389/fonc.2023.1153662
pmc: PMC10291180
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1153662

Informations de copyright

Copyright © 2023 Di Perna, De Marco, Baldassarre, Lo Bue, Cofano, Zeppa, Ceroni, Penner, Melcarne, Garbossa, Lanotte and Zenga.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Lancet Oncol. 2016 Sep;17(9):e383-91
pubmed: 27599143
Clin Otolaryngol Allied Sci. 1999 Dec;24(6):483-6
pubmed: 10606992
Otol Neurotol. 2018 Feb;39(2):232-241
pubmed: 29315189
Otol Neurotol. 2002 May;23(3):388-92
pubmed: 11981400
Laryngoscope. 1999 Jun;109(6):922-6
pubmed: 10369283
Neurosurgery. 1997 Apr;40(4):684-94; discussion 694-5
pubmed: 9092841
J Neurol Surg B Skull Base. 2012 Feb;73(1):21-7
pubmed: 23372991
World Neurosurg. 2020 Nov;143:e36-e43
pubmed: 32305604
Clin Neurol Neurosurg. 2015 Jun;133:83-9
pubmed: 25867236
J Neurosurg. 2010 Apr;112(4):860-7
pubmed: 19663543
Otol Neurotol. 2005 Jul;26(4):728-32
pubmed: 16015176
Ann Otol Rhinol Laryngol. 1992 Oct;101(10):821-6
pubmed: 1416636
Otol Neurotol. 2003 Jul;24(4):642-8; discussion 648-9
pubmed: 12851559
Acta Neurochir (Wien). 2015 Nov;157(11):1991-7; discussion 1998
pubmed: 26347044
Acta Neurochir (Wien). 2020 May;162(5):1197-1203
pubmed: 32146526
Front Oncol. 2022 Feb 11;11:770789
pubmed: 35223451
Neurosurgery. 2012 Jun;70(6):1481-91; discussion 1491
pubmed: 22270232
Otolaryngol Head Neck Surg. 1985 Apr;93(2):146-7
pubmed: 3921901
Neurosurgery. 1997 Jan;40(1):11-21; discussion 21-3
pubmed: 8971819
Neurosurg Rev. 2005 Jul;28(3):209-13
pubmed: 15739069
Laryngoscope. 2021 Apr;131(4):E1328-E1334
pubmed: 33006401
Acta Neurochir (Wien). 2020 Nov;162(11):2595-2617
pubmed: 32728903
J Neurosurg. 2006 Aug;105(2):205-12
pubmed: 17219824
J Neurosurg. 2007 May;106(5):866-71
pubmed: 17542531
World Neurosurg. 2013 Dec;80(6):e271-300
pubmed: 22120256
Neuro Oncol. 2020 Jan 11;22(1):31-45
pubmed: 31504802
Neurol Neurochir Pol. 2016;50(1):36-44
pubmed: 26851688
Neurosurgery. 2016 Feb;78(2):251-5
pubmed: 26352097
World Neurosurg. 2018 Mar;111:e267-e276
pubmed: 29258928
Otolaryngol Head Neck Surg. 2007 May;136(5):773-7
pubmed: 17478214
Otol Neurotol. 2006 Oct;27(7):1017-22
pubmed: 17006353
Head Neck. 2016 Aug;38(8):1158-63
pubmed: 27225347
Arch Otolaryngol Head Neck Surg. 1992 Oct;118(10):1061-4
pubmed: 1389057
Otolaryngol Head Neck Surg. 2021 May;164(5):1085-1093
pubmed: 33048002
Otol Neurotol. 2016 Sep;37(8):1162-7
pubmed: 27525626
J Neurosurg. 1989 Dec;71(6):799-804
pubmed: 2641991
J Neurosurg. 2007 May;106(5):826-32
pubmed: 17542526
Eur Arch Otorhinolaryngol. 2016 Dec;273(12):4215-4223
pubmed: 27312994
J Neurosurg. 1998 Mar;88(3):506-12
pubmed: 9488305
J Neurosurg. 2003 Nov;99(5):818-23
pubmed: 14609159
Acta Neurochir (Wien). 1991;110(3-4):120-3
pubmed: 1927602
World Neurosurg. 2016 May;89:215-22
pubmed: 26826537
World Neurosurg. 2019 Jul;127:e599-e608
pubmed: 30930324
J Neurosurg. 1997 Jul;87(1):60-6
pubmed: 9202266
Clin Otolaryngol. 2017 Feb;42(1):92-97
pubmed: 27158933
World J Otorhinolaryngol Head Neck Surg. 2016 Dec 24;2(4):234-239
pubmed: 29204572
J Neurosurg. 2011 Nov;115(5):875-84
pubmed: 21838510
Ann Otol Rhinol Laryngol. 2007 Jul;116(7):542-9
pubmed: 17727086
Neurosurgery. 2000 May;46(5):1140-6; discussion 1146-8
pubmed: 10807246

Auteurs

Giuseppe Di Perna (G)

Department of Neuroscience "Rita Levi Montalcini", University of Turin, Turin, Italy.
Skull Base and Pituitary Surgery Unit, "Città della Salute e della Scienza" University Hospital, Turin, Italy.
Spine Surgery Unit, Casa di Cura "Città di Bra", Bra, Cuneo, Italy.

Raffaele De Marco (R)

Department of Neuroscience "Rita Levi Montalcini", University of Turin, Turin, Italy.
Skull Base and Pituitary Surgery Unit, "Città della Salute e della Scienza" University Hospital, Turin, Italy.

Bianca Maria Baldassarre (BM)

Department of Neuroscience "Rita Levi Montalcini", University of Turin, Turin, Italy.
Skull Base and Pituitary Surgery Unit, "Città della Salute e della Scienza" University Hospital, Turin, Italy.

Enrico Lo Bue (E)

Department of Neuroscience "Rita Levi Montalcini", University of Turin, Turin, Italy.
Skull Base and Pituitary Surgery Unit, "Città della Salute e della Scienza" University Hospital, Turin, Italy.

Fabio Cofano (F)

Department of Neuroscience "Rita Levi Montalcini", University of Turin, Turin, Italy.
Spine Surgery Unit, Humanitas Gradenigo Hospital, Turin, Italy.

Pietro Zeppa (P)

Department of Neuroscience "Rita Levi Montalcini", University of Turin, Turin, Italy.

Luca Ceroni (L)

Department of Psychology, University of Turin, Turin, Italy.

Federica Penner (F)

Department of Neuroscience "Rita Levi Montalcini", University of Turin, Turin, Italy.
Skull Base and Pituitary Surgery Unit, "Città della Salute e della Scienza" University Hospital, Turin, Italy.

Antonio Melcarne (A)

Department of Neuroscience "Rita Levi Montalcini", University of Turin, Turin, Italy.
Neurosurgery Unit, "Città della Salute e della Scienza" University Hospital, Turin, Italy.

Diego Garbossa (D)

Department of Neuroscience "Rita Levi Montalcini", University of Turin, Turin, Italy.
Neurosurgery Unit, "Città della Salute e della Scienza" University Hospital, Turin, Italy.

Michele Maria Lanotte (MM)

Department of Neuroscience "Rita Levi Montalcini", University of Turin, Turin, Italy.
Functional, Oncological and Stereotactic Neurosurgery Unit, "Città della Salute e delle Scienza" University Hospital, Turin, Italy.

Francesco Zenga (F)

Skull Base and Pituitary Surgery Unit, "Città della Salute e della Scienza" University Hospital, Turin, Italy.
Neurosurgery Unit, "Città della Salute e della Scienza" University Hospital, Turin, Italy.

Classifications MeSH